- Home
- TNYA vs TKNO Comparison
TNYA vs TKNO Comparison
Compare TNYA & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNYA
- TKNO
- Stock Information
- Founded
- TNYA 2016
- TKNO 1996
- Country
- TNYA United States
- TKNO United States
- Employees
- TNYA N/A
- TKNO N/A
- Industry
- TNYA Medicinal Chemicals and Botanical Products
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- TNYA Health Care
- TKNO Health Care
- Exchange
- TNYA Nasdaq
- TKNO Nasdaq
- Market Cap
- TNYA 326.0M
- TKNO 340.9M
- IPO Year
- TNYA 2021
- TKNO 2021
- Fundamental
- Price
- TNYA $1.27
- TKNO $4.46
- Analyst Decision
- TNYA Strong Buy
- TKNO
- Analyst Count
- TNYA 5
- TKNO 0
- Target Price
- TNYA $8.60
- TKNO N/A
- AVG Volume (30 Days)
- TNYA 3.9M
- TKNO 188.7K
- Earning Date
- TNYA 11-10-2025
- TKNO 11-06-2025
- Dividend Yield
- TNYA N/A
- TKNO N/A
- EPS Growth
- TNYA N/A
- TKNO N/A
- EPS
- TNYA N/A
- TKNO N/A
- Revenue
- TNYA N/A
- TKNO $39,801,000.00
- Revenue This Year
- TNYA N/A
- TKNO $9.52
- Revenue Next Year
- TNYA N/A
- TKNO $15.20
- P/E Ratio
- TNYA N/A
- TKNO N/A
- Revenue Growth
- TNYA N/A
- TKNO 9.50
- 52 Week Low
- TNYA $0.36
- TKNO $3.94
- 52 Week High
- TNYA $4.01
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- TNYA 39.57
- TKNO 39.80
- Support Level
- TNYA $1.20
- TKNO $4.26
- Resistance Level
- TNYA $1.56
- TKNO $4.55
- Average True Range (ATR)
- TNYA 0.14
- TKNO 0.38
- MACD
- TNYA -0.02
- TKNO -0.07
- Stochastic Oscillator
- TNYA 16.67
- TKNO 23.17
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.